9 results on '"Mangschau, Arild"'
Search Results
2. [A man in his sixties with myocardial infarction, stent thrombosis and haemorrhage].
- Author
-
Tjugen TB, Eritsland J, Mangschau A, and Andersen GØ
- Subjects
- Abciximab, Angioplasty, Balloon, Antibodies, Monoclonal adverse effects, Antibodies, Monoclonal therapeutic use, Anticoagulants therapeutic use, Coronary Artery Bypass, Coronary Disease diagnosis, Coronary Disease therapy, Coronary Thrombosis diagnosis, Coronary Thrombosis etiology, Hematuria complications, Humans, Immunoglobulin Fab Fragments adverse effects, Immunoglobulin Fab Fragments therapeutic use, Male, Middle Aged, Myocardial Infarction diagnosis, Myocardial Infarction drug therapy, Recurrence, Thrombocytopenia chemically induced, Urinary Bladder Neoplasms complications, Anticoagulants adverse effects, Coronary Thrombosis drug therapy, Hemorrhage chemically induced, Myocardial Infarction therapy, Stents adverse effects
- Abstract
A man in his sixties had acute ST-elevation myocardial infarction (treated with PCI [percutaneous coronary intervention] and antithrombotic medication) complicated by recurrent stent thrombosis. Excessive haematuria and discovery of a urinary bladder cancer complicated the antithrombotic treatment. Due to recurrent stent thrombosis the patient underwent a total of four PCIs and received the glycoprotein IIb/IIIa-inhibitor abciximab on two occasions. After the last administration of abciximab he developed excessive bleeding within an hour; a blood sample revealed severe thrombocytopenia (2 x 10(9)/l). Severe thrombocytopenia is a rare, but well-known complication to glycoprotein IIb/IIIa-inhibitor treatment and is most often seen after readministration of abciximab. The problem of recurrent coronary stent thrombosis was solved by aorto-coronary bypass surgery, which should always be considered in patients with recurrent stent thrombosis and complications to anti-thrombotic treatment. When bleeding occurs in connection with abciximab treatment, especially within the first month after previous treatment, severe thrombocytopenia should always be considered as a possible cause. Abciximab should be avoided in patients with a history of severe abciximab-related thrombocytopenia.
- Published
- 2010
- Full Text
- View/download PDF
3. [Impaired glucose tolerance in patients with acute myocardial infarction].
- Author
-
Andersen GØ, Eritsland J, Aasheim A, Neuburger J, Knudsen EC, and Mangschau A
- Subjects
- Adult, Aged, Aged, 80 and over, Diabetes Mellitus, Type 2 blood, Diabetes Mellitus, Type 2 complications, Female, Glucose Intolerance complications, Glucose Tolerance Test, Humans, Lipids blood, Male, Middle Aged, Myocardial Infarction complications, Myocardial Infarction mortality, Prognosis, Prospective Studies, Blood Glucose metabolism, Glucose Intolerance blood, Myocardial Infarction blood
- Abstract
Background: Diabetes and impaired glucose tolerance are associated with increased mortality in patients with acute myocardial infarction. We have used standardised oral glucose tolerance tests shortly after a myocardial infarction., Methods: 109 patients admitted with acute myocardial infarction were prospectively enrolled in the study. An oral glucose tolerance test was performed the first morning the patients were stable, without pain, nausea or hyperglycaemia. The patients were classified into normal glucose tolerance, impaired glucose tolerance or diabetes, according to the results of the oral glucose tolerance test and fasting plasma glucose levels., Results: 109 patients (25 women) were included. Eight patients were previously diagnosed with diabetes type 2. Oral glucose tolerance was tested for 90 patients, usually the day after admission. The test was positive in 47 patients; 32 of them had 2-h plasma glucose levels between 7.8 and 11.0 mmol/L and were classified as having impaired glucose tolerance, and 15 had 2-h plasma glucose > or = 11.1 mmol/L and were classified as newly diagnosed diabetes patients. Similar body mass indexes and lipid values were found in patients with different glycometabolic states. Smoking was associated with a positive oral glucose tolerance test., Interpretation: More than half of the patients with acute myocardial infarction had undiagnosed impaired glucose tolerance or diabetes type 2, as determined by an oral glucose tolerance test. The test could easily be performed shortly after a myocardial infarction in most of the patients. Oral glucose tolerance testing should be considered in all patients with coronary heart disease without a history of diagnosed diabetes.
- Published
- 2006
4. [Primary angioplasty in acute ST elevation myocardial infarction in the elderly].
- Author
-
Eritsland J, Kløw NE, Westheim A, Bendz B, and Mangschau A
- Subjects
- Aged, Aged, 80 and over, Coronary Angiography, Female, Humans, Male, Middle Aged, Myocardial Infarction diagnosis, Myocardial Infarction mortality, Retrospective Studies, Treatment Outcome, Angioplasty, Balloon, Coronary, Myocardial Infarction therapy
- Abstract
Background: Based on data from the literature, it has been suggested that elderly patients with acute myocardial infarction will benefit more from primary angioplasty than from thrombolysis., Material and Methods: Data for 100 consecutive patients, age 75 years or more, presenting with an acute ST elevation myocardial infarction (STEMI) without cardiogenic shock and treated with primary angioplasty were analysed retrospectively. Some variables were compared with previously published data on a group of 100 younger patients (mean age 59) with STEMI., Results: Angiographically, the success rate of revascularization was similar between the elderly (mean age 80) and the younger STEMI patients. Mortality, both at 30 days and at 1 year, was higher among the elderly patients compared with the younger (15% vs. 1% and 21% vs. 3% respectively, both p < 0.001). In the same time period, primary angioplasty was performed in seven patients > or = 75 years who presented with cardiogenic shock at admission. All of these died during hospitalization., Interpretation: Technically, the success rate of primary angioplasty in elderly patients with STEMI was similar to that in younger STEMI patients. Mortality after 30 days was significantly higher among the elderly patients, but the mortality rate from 30 days to 1 year after the infarction was similar to that of the same age group in the general population. Patients > or = 75 years presenting with STEMI and cardiogenic shock had no benefit of angioplasty; all died during hospitalization.
- Published
- 2005
5. [Cardiogenic shock-- new therapeutic strategies].
- Author
-
Andersen GØ, Eritsland J, Bjørnerheim R, Kløw NE, Jonassen A, and Mangschau A
- Subjects
- Cardiotonic Agents therapeutic use, Humans, Hydrazones therapeutic use, Intra-Aortic Balloon Pumping, Male, Middle Aged, Myocardial Infarction complications, Myocardial Revascularization, Pyridazines therapeutic use, Shock, Cardiogenic drug therapy, Shock, Cardiogenic etiology, Shock, Cardiogenic surgery, Simendan, Shock, Cardiogenic therapy
- Abstract
Background: Cardiogenic shock is a condition associated with high mortality. The evidence base for choice of treatment is insufficient, but new therapeutic options and new understanding have lead to some improvement in the prognosis. A new class of heart failure medication is now approved in Norway (calcium sensitizers)., Methods: We present a case history that illustrates new options in the treatment of cardiogenic shock complicating acute myocardial infarction. We have searched available literature and give a review of the treatment of cardiogenic shock with special emphasis on the role of inotropic drug therapy., Results and Interpretation: A 46-year-old man with cardiogenic shock complicating myocardial infarction because of occlusion of the left-main coronary artery was treated with acute revascularization, intra-aortic balloon counterpulsation (IABP) and levosimendan. Early revascularization is a key factor in the treatment of cardiogenic shock; rapid transfer of patients to a revascularization centre is recommended. IABP should be considered after successful revascularization because of post-ischaemic dysfunction that persists despite restoration of epicardial blood flow. Beta-adrenergic stimulation of the heart should, if possible, be avoided, because of increased myocardial oxygen requirement, calcium overload of the cardiomyocytes, and increased mortality. Drug therapy using calcium sensitizers is promising, but more controlled clinical trials are needed.
- Published
- 2005
6. [Reduction of myocardial infarction size after primary percutaneous coronary intervention].
- Author
-
Pettersen AA, Müller C, Bendz B, Halvorsen S, Eritsland J, Brekke M, and Mangschau A
- Subjects
- Adult, Female, Humans, Male, Middle Aged, Myocardial Infarction diagnostic imaging, Myocardial Reperfusion, Radionuclide Imaging, Angioplasty, Balloon, Coronary methods, Myocardial Infarction therapy
- Abstract
Background: Achieving reperfusion as soon as possible is essential in order to reduce myocardial infarction size and thus improve prognosis. An increasing number of patients with myocardial infarction are treated with primary percutaneous coronary intervention (PCI). Technetium 99m-tetrofosmin myocardial perfusion tomography (SPECT) is a valid test for assessing myocardium at risk and final infarct size expressed by a hypoperfusion index (HPI) of the left ventricular mass., Material and Methods: 20 patients with acute ST-elevation myocardial infarction were treated with primary percutaneous coronary intervention within six hours of onset of symptoms. Myocardium at risk and final infarct size were assessed by Technetium 99m-tetrofosmin immediately before and a few hours, one week and six weeks after., Results: The hypoperfusion index immediately before percutaneous coronary intervention was 31%, four to six hours after PCI 25%, one week later 16% and six weeks later 12%, i.e. a relative reduction of 60% (p < 0.01). Anterior wall infarctions had a higher level of myocardium at risk before primary PCI compared to inferior wall infarctions (36% vs. 24%), but anterior wall infarctions had a higher salvage index compared to inferior wall infarctions., Interpretation: This non-controlled study shows a marked reduction in final infarction size in patients with acute ST-elevation myocardial infarction treated with primary PCI.
- Published
- 2004
7. [Aortic dissection--a differential diagnosis in patients with chest pain and ECG changes].
- Author
-
Fossum E, Ata B, Eritsland J, Kløw NE, and Mangschau A
- Subjects
- Adult, Aged, Contraindications, Coronary Angiography, Diagnosis, Differential, Electrocardiography, Female, Humans, Male, Middle Aged, Myocardial Infarction diagnosis, Retrospective Studies, Thrombolytic Therapy, Aortic Dissection diagnosis, Angina Pectoris diagnosis, Aorta, Thoracic, Aortic Aneurysm diagnosis
- Abstract
Background: The effect of thrombolytic therapy in patients with myocardial infarction is well documented. In patients presenting with chest pain it may, however, be difficult to discriminate between myocardial infarction and aortic dissection only on the basis of clinical manifestations. Moreover, patients with type A dissection may have ECG changes caused by affection of the coronary flow., Material and Methods: We retrospectively investigated all patients admitted to our hospital with type A dissection of the aorta over the period 1999 to March 2001., Results: Fourteen patients were identified. Only two patients had normal ECG, six had ST elevation. Two patients had received antithrombotic or thrombolytic therapy., Interpretation: In patients with chest pain and ST elevation, aortic dissection must be considered as a differential diagnosis before thrombolytic therapy.
- Published
- 2003
8. [Prehospital ECG reduces time to treatment with percutaneous coronary interventions].
- Author
-
Aasheim A, Bendz B, Naess AC, Steen PA, Wik L, and Mangschau A
- Subjects
- Aged, Aged, 80 and over, Ambulances, Female, Humans, Male, Middle Aged, Myocardial Infarction therapy, Norway, Patient Admission, Time Factors, Workforce, Angioplasty, Balloon, Coronary, Electrocardiography, Emergency Medical Services, Myocardial Infarction diagnosis
- Published
- 2003
9. [Left ventricular function and infarction size after primary angioplasty for acute myocardial infarction].
- Author
-
Halvorsen S, Müller C, Bendz B, Eritsland J, Brekke M, and Mangschau A
- Subjects
- Aged, Female, Follow-Up Studies, Heart Ventricles diagnostic imaging, Humans, Male, Middle Aged, Myocardial Infarction physiopathology, Stents, Tomography, Emission-Computed, Single-Photon, Angioplasty, Balloon, Coronary, Myocardial Infarction diagnosis, Myocardial Infarction surgery, Ventricular Function, Left physiology
- Abstract
Background: There is little information available on long-term changes in left ventricular function and infarct size after acute myocardial infarction treated with primary angioplasty., Material and Methods: From 1996 to 1998, 100 consecutive patients were treated with primary angioplasty for acute ST-elevation myocardial infarction. Left ventricular ejection fraction was determined by radionuclide ventriculography before discharge, after six weeks and after a mean follow-up time of 20 months (range 11-37). Infarct size was assessed by technetium 99m-tetrofosmin myocardial perfusion tomography (SPECT) at rest, performed at the same time intervals., Results: Mean ejection fraction was 56% at discharge, 55% after six weeks and 57% after 20 months of follow-up. A mean perfusion defect of 19% was measured by SPECT after one week. After six weeks and 20 months of follow-up, the mean perfusion defects were reduced to 14% (p < 0.001) and 15%, respectively., Interpretation: Left ventricular function was well preserved and infarct sizes small to moderate 20 months (range 11-37) after primary angioplasty for acute myocardial infarction, demonstrating that the initial successful effect of the treatment was maintained.
- Published
- 2002
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.